A (class-)switch in the antibody response may distinguish primary from secondary dengue virus infection

EBioMedicine. 2020 Jun:56:102790. doi: 10.1016/j.ebiom.2020.102790. Epub 2020 May 23.

Authors

Lisa Levoir¹, Leslie Goo²

Affiliations

¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, United States.
² Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, United States. Electronic address: lgoo@fredhutch.org.

No abstract available

Publication types

Comment

MeSH terms

Antibody Formation
Dengue Virus*
Dengue*
Humans